Oxidative DNA damage in early pregnancy and risk of gestational diabetes mellitus: A pilot study

Clinical Biochemistry

Volumn 44, Issue 10-11, 2011, Pages 804-808

  Qiu, Chunfang ^a   Hevner, Karin ^a   Abetew, Dejene ^a   Enquobahrie, Daniel A ^a,b   Williams, Michelle A ^a,b  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gestational diabetes mellitus; Oxidative DNA damage; Oxidative stress; Pregnancy; Urinary 8 OHdG concentrations

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CREATININE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; DNA REPAIR; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PILOT STUDY; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINALYSIS;

ADULT; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DEMOGRAPHY; DEOXYGUANOSINE; DIABETES, GESTATIONAL; DNA DAMAGE; FEMALE; HUMANS; ODDS RATIO; OXIDATIVE STRESS; PILOT PROJECTS; PREGNANCY; RISK FACTORS; WASHINGTON; YOUNG ADULT;

EID: 79958776310     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.04.023     Document Type: Article

References (39)

1. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 1999, Oxford Univ Press, Oxford. 3rd ed.
2. Erhola M., Toyokuni S., Okada K., Tanaka T., Hiai H., Ochi H., Uchida K., Osawa T., Nieminen M.M., Alho H., Kellokumpu-Lehtinen P. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-20-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS. Lett. 1997, 409:287-291.
3. Loft S., Vistisen K., Ewertz M., Tjonneland A., Overad K., Poulsen H.E. OxidativeDNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992, 13:2241-2247.
4. Chuma M., Hige S., Nakanishi M., Ogawa K., Natsuizaka M., Yamamoto Y., Asaka M. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 2008, 23:1431-1436.
5. Kageyama Y., Takahashi M., Ichikawa T., Torikai E., Nagano A. Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2008, 26:73-80.
6. Goodarzi M.T., Navidi A.A., Rezaei M., Babahmadi-Rezaei H. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J. Clin. Lab. Anal. 2010, 24:72-76.
7. Mahmoud M., Mercer J., Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc. Res. 2006, 71:259-268.
8. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008, 198:347-353.
9. Leinonen J., Lehtimäki T., Toyokuni S., Okada K., Tanaka T., Hiai H., Ochi H., Laippala P., Rantalaiho V., Wirta O., Pasternack A., Alho H. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 1997, 417:150-152.
10. Nishikawa T., Sasahara T., Kiritoshi S., Sonoda K., Senokuchi T., Matsuo T., Kukidome D., Wake N., Matsumura T., Miyamura N., Sakakida M., Kishikawa H., Araki E. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care. 2003, 26:1507-1512.
11. Nakanishi S., Suzuki G., Kusunoki Y., Yamane K., Egusa G., Kohno N. Increasing of oxidative stress from mitochondria in type 2 diabetic patients. Diabetes. Metab. Res. Rev. 2004, 20:399-404.
12. Endo K., Miyashita Y., Sasaki H., Ebisuno M., Ohira M., Saiki A., Koide N., Oyama T., Takeyoshi M., Shirai K. Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia. J. Atheroscler. Thromb. 2006, 13:68-75.
13. Negishi H., Ikeda K., Kuga S., Noguchi T., Kanda T., Njelekela M., Liu L., Miki T., Nara Y., Sato T., Mashalla Y., Mtabaji J., Yamori Y. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J. Hypertens. 2001, 19:529-533.
14. Scholl T.O., Stein T.P. Oxidant damage to DNA and pregnancy outcome. J. Matern. Fetal. Med. 2001, 10:182-185.
15. Rudra C.B., Qiu C., David R.M., Bralley J.A., Walsh S.W., Williams M.A. A prospective study of early-pregnancy plasma malondialdehyde concentration and risk of preeclampsia. Clin. Biochem. 2006, 39:722-726.
16. Peter Stein T., Scholl T.O., Schluter M.D., Leskiw M.J., Chen X., Spur B.W., Rodriguez A. Oxidative stress early in pregnancy and pregnancy outcome. Free. Radic. Res. 2008, 42:841-848.
17. Karowicz-Bilinska A., Suzin J., Sieroszewski P. Evaluation of oxidative stress indices during treatment in pregnant women with intrauterine growth retardation. Med. Sci. Monit. 2002, 8. CR211-216.
18. Min J., Park B., Kim Y.J., Lee H., Ha E., Park H. Effect of oxidative stress on birth sizes: consideration of window from mid pregnancy to delivery. Placenta 2009, 30:418-423.
19. Zhang C., Qiu C., Hu F.B., David R.M., van Dam R.M., Bralley A., Williams M.A. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One. 2008, 3:e3753.
20. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes. Care. 2003, 26:S5-S20.
21. Cooke M., Evan M.D., Herbert K.E., Lunec J. Urinary 8-oxo-2'deoxyguanosine-source, significance, and supplements. Free. Radic. Res. 2000, 32:381-397.
22. Yin B., Whyatt R.M., Perera F.P., Randall M.C., Cooper T.B., Santella R.M. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free. Radic. Biol. Med. 1995, 18:1023-1032.
23. Miyazaki Y., Kawano H., Yoshida T., Miyamoto S., Hokamaki J., Nagayoshi Y., Yamabe H., Nakamura H., Yodoi J., Ogawa H. Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia. Diabet. Med. 2007, 24:154-160.
24. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
25. Ihara Y., Toyokuni S., Uchida K., Odaka H., Tanaka T., Ikeda H., Hiai H., Seino Y., Yamada Y. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999, 48:927-932.
26. Zhang C., Williams M.A., Frederick I.O., King I.B., Sorensen T.K., Kestin M.M., Dashow E.E., Luthy D.A. Vitamin C and the risk of gestational diabetes mellitus: a case-control study. J. Reprod. Med. 2004, 48:257-266.
27. Biri A., Onan A., Devrim E., Babacan F., Kavutcu M., Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 2006, 27:327-332.
28. Grissa O., Atègbo J.M., Yessoufou A., Tabka Z., Miled A., Jerbi M., Dramane K.L., Moutairou K., Prost J., Hichami A., Khan N.A. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl. Res. 2007, 150:164-171.
29. Lappas M., Mitton A., Permezel M. In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J. Endocrinol. 2010, 204:75-84.
30. Boisvert M.R., Koski K.G., Skinner C.D. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal. Chem. 2010, 82:1133-1137.
31. Coughlan M.T., Vervaart P.P., Permezel M., Georgiou H.M., Rice G.E. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 2004, 25:78-84.
32. Kinalski M., Sledziewski A., Telejko B., Kowalska I., Kretowski A., Zarzycki W., Kinalska I. Lipid peroxidation, antioxidant defense and acid-base status in cord blood at birth: the influence of diabetes. Horm. Metab. Res. 2001, 33:227-231.
33. Mazzanti L., Nanetti L., Vignini A., Rabini R.A., Grechi G., Cester N., Curzi C.M., Tranquilli A.L. Gestational diabetes affects platelet behavior through modified oxidative radical metabolism. Diabet. Med. 2004, 21:68-72.
34. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004, 24:816-823.
35. Robertson R.P., Harmon J., Tran P.O., Tanaka Y., Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581-587.
36. Paolisso G., Giugliano D. Oxidative stress and insulin action: is there a relationship?. Diabetologia 1996, 39:357-363.
37. Rudich A., Kozlovsky N., Potashnik R., Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am. J. Physiol. 1997, 272:E935-E940.
38. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 2003, 52:1-8.
39. Roebuck K.A. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappa B. Int. J. Mol. Med. 1999, 4:223-230.